Report: Strategic Analysis of the Opportunities for the Pharmaceutical and Biotechnology Industry in the 'New' EU Countries TOC

Strategic Analysis of the Opportunities for the Pharmaceutical and Biotechnology Industry in the 'New' EU Countries

Published by

Frost & Sullivan

Published

2004/12

Content info

Product code

FS26336

Price

From US $ 4950

PDF by E-Mail

Approx. 1-2 business days

Hard Copy/CD-ROM

Approx. 3-4 business days

If you need expedited delivery, please call us.

1 STRATEGIC ANALYSIS OF THE OPPORTUNITIES FOR PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY IN THE NEW EU COUNTRIES

Overview

Research Scope and Methodology

European Union

European Union Healthcare

Challenges in the New EU Market

Opportunities in Clinical Trials

Strategic Recommendations

Industry Participants

Decision Support Databases

About Frost & Sullivan

Our Team
Consulting Capabilities

Strategic Analysis of the Opportunities for the Pharmaceutical and Biotechnology Industry in the 'New' EU Countries

Table of Contents

1 STRATEGIC ANALYSIS OF THE OPPORTUNITIES FOR PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY IN THE NEW EU COUNTRIES